Test Information: Encephalitis is a debilitating neurologic condition caused by infectious and autoimmune conditions that result in inflammation of the brain parenchyma. The identification of autoantibodies may augment a diagnosis of autoimmune encephalitis, but is not required for the diagnosis or initiation of therapy. The most frequently identified antibodies target NMDA-R. We recommend ordering NMDA Receptor IgG Antibody with Reflex, CSF (Sendout) [RCNMDA] as first-line testing for autoimmune encephalitis prior to ordering this full panel.
Monitoring titers over time for these antibodies is not recommended; however, this recommendation is based on limited currently available literature.
Test Algorithm: Reflex testing may be performed at additional charge. Refer to Mayo's algorithm (linked below) for additional detail on tests and potential reflex tests included in this panel.
Ordering Guidance: Refer to Autoimmune Encephalitis Testing Recommendations or consult the Laboratory Medicine Resident on-call.
Code | Name |
---|---|
RCENCI | Encephalopathy, Interpretation, CSF |
RIFANT | IFA Notes |
RCAMPA | AMPA Receptor Ab CBA, CSF |
RCAMPH | Amphiphysin Ab, CSF |
RCAGN1 | Anti Glial Nuclear Ab, Type 1, CSF |
RCANA1 | Anti Neuronal Nuclear Ab Type 1, CSF |
RCANN2 | Anti Neuronal Nuclear Ab Type 2, CSF |
RCANN3 | Anti Neuronal Nuclear Ab Type 3, CSF |
RCSPR2 | CASPR2 IgG CBA, CSF |
RCRMP5 | CRMP 5 IgG, CSF |
RCDPPC | DPPX Antibody CBA, CSF |
RCGABA | GABA B Receptor Ab CBA, CSF |
RCGD65 | GAD65 Ab Assay, CSF |
RCGFAP | GFAP IFA, CSF |
RCMGR1 | mGluR1 Ab IFA, CSF |
RCIG5C | IgLON5 CBA, CSF |
RCLGI1 | LGI1 IgG CBA, CSF |
RNCDIC | Neurochondrin IFA, CSF |
RNIFIC | NIF IFA, CSF |
RCNMDC | NMDA Receptor Ab CBA, CSF |
RCPCAT | Purkinje Cell Cytoplasmc Ab Type Tr, CSF |
RCPCY1 | Purkinje Cell Cytoplasmic Ab Type 1, CSF |
RCPCA2 | Purkinje Cell Cytoplasmic Ab Type 2, CSF |
RCPDE1 | PDE10A Antibody IFA, CSF |
RSP7IC | Septin 7 IFA, CSF |
RCTR46 | TRIM46 Antibody IFA, CSF |
Indirect Immunofluorescence Assay (IFA): ANNA-1, ANNA-2, ANNA-3, AGNA-1, PCA-1, PCA-2, PCA-Tr, Amphiphysin Ab, CRMP-5 IgG, GFAP, mGluR1 Ab, Neurochondrin Ab, Septin-7 Antibody, PDE10A Ab, TRIM46 Ab
Cell-Binding Assay (CBA): AMPA-R Ab, GABA-B-R Ab, NMDA-R Ab CBA, LGI1-IgG CBA, CASPR2-IgG, DPPX Ab, IgLON5 Ab
Radioimmunoassay (RIA): GAD65 Ab
Reference Values:
AMPA-R Ab CBA, CSF: | Negative |
Amphiphysin Ab, CSF: | Negative |
Anti-Glial Nuclear Ab, Type 1, CSF: | Negative |
Anti-Neuronal Nuclear Ab, Type 1, CSF: | Negative |
Anti-Neuronal Nuclear Ab, Type 2, CSF: | Negative |
Anti-Neuronal Nuclear Ab, Type 3, CSF: | Negative |
CASPR2-IgG CBA, CSF: | Negative |
CRMP-5-IgG, CSF: | Negative |
DPPX Ab CBA, CSF: | Negative |
GABA-B-R Ab CBA, CSF: | Negative |
GAD65 Ab Assay, CSF: | < or =0.02 nmol/L |
GFAP IFA, CSF: | Negative |
mGluR1 Ab IFA, CSF: | Negative |
IgLON5 CBA, CSF: | Negative |
LGI1-IgG CBA, CSF: | Negative |
Neurochondrin IFA, CSF: | Negative |
NIF IFA, CSF: | Negative |
NMDA-R Ab CBA, CSF: | Negative |
Purkinje Cell Cytoplasmc Ab Type Tr: | Negative |
Purkinje Cell Cytoplasmic Ab Type 1: | Negative |
Purkinje Cell Cytoplasmic Ab Type 2: | Negative |
PDE10A Ab IFA, CSF: | Negative |
Septin-7 IFA, CSF: | Negative |
TRIM46 IFA, CSF: | Negative |
Note: Includes reference values for panel tests only.
Neuron-restricted patterns of IgG staining that do not fulfill criteria for ANNA-1, ANNA-2, ANNA-3, CRMP-5-IgG, PCA-1, PCA-2, or PCA-Tr may be reported as "unclassified anti-neuronal IgG." Complex patterns that include nonneuronal elements may be reported as "uninterpretable."
CRMP-5 titers lower than 1:2 are detectable by recombinant CRMP-5 Western blot analysis. CRMP-5 Western blot analysis will be done on request on stored spinal fluid (held 4 weeks). This supplemental testing is recommended in cases of chorea, vision loss, cranial neuropathy, and myelopathy. Call the Neuroimmunology Laboratory at 800-533-1710 to request CRMP-5 Western blot.
Interpretation:
Neuronal, glial, and muscle autoantibodies are valuable serological markers of autoimmune encephalopathy and of a patient's immune response to cancer. These autoantibodies are usually accompanied by subacute neurological symptoms and signs are not found in healthy subjects. It is not uncommon for more than 1 of the following autoantibody specificities to be detected in patients with an autoimmune encephalopathy:
This test is intended to be ordered for adult patients. If this test is ordered for a patient younger than 18 years of age, it will be canceled and automatically reordered by the laboratory as PCDEC/ Pediatric Autoimmune Encephalopathy/CNS Disorder Evaluation, Spinal Fluid. The pediatric autoimmune CNS disorders evaluation is part of an evolving approach to testing for autoimmune neurological disorders using phenotypic-specific evaluations that include multiple antibodies known for their disease association.
Collect 4 mL CSF and transfer to a sterile vial.
Outside Laboratories: Refrigerate CSF in a sterile vial.
Stability: Refrigerated (preferred): 28 days; Frozen: 28 days; Ambient: 72 hours.
SPS: Use container code CSF4 to route this order in Sunquest SMART.
Refrigerate CSF in a sterile vial.
Sendouts:
Stability: Refrigerated (preferred): 28 days; Frozen: 28 days; Ambient: 72 hours.
Sendout |
Mayo Clinic Laboratories
800-533-1710 200 First Street Southwest |
---|
Reflex testing may be performed at additional charge.